CTRI/2013/11/004150Recruiting未知
Medanta Cardiometabolic Disease Study
Medanta Duke Research Institute0 sites700 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 700
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •I.Are 18-80 years old,
- •II.Have the ability to give informed consent and
- •III.Are a patient at the Medanta-The Medicity Hospital outpatient clinic, cardiac catheterization laboratory or at the rural camps organized by the Medanta-The Medicity Hospital you are eligible to participate in the study.
- •IV.Are undergoing a cardiac catheterization, it should be because there is a concern for coronary artery disease and the cardiac catheterization should not be an emergency procedure.
Exclusion Criteria
- •I.Are being unable to give informed consent,
- •II.Are undergoing an emergency cardiac catheterization,
- •III.Are having severe anemia,
- •IV.Are having a planned surgery within 24 hours of cardiac catheterization.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Randomised controlled trial to test whether text message reminders sent to women with previous gestational diabetes helps improve testing for type 2 diabetesISRCTN13791687niversity of Birmingham600
Not yet recruiting
Not Applicable
A cohort study on correlation between the progression of metabolic diseases and dampness constitution of Chinese Medicinemetabolic disease and dampness constitution of CMITMCTR2100005307Guangdong Provincial Hospital of Chinese Medicine
Completed
Not Applicable
Validation study for anti-metabolic syndrome effect and intestinal functions in healthy Japanese adults: a double-blind randomized controlled trialHealthy adultsJPRN-UMIN000017943ORTHOMEDICO, Inc.32
Active, not recruiting
Phase 1
Investigating the effects of mildly increased cortisol secretion on cardio metabolic risk factorsEUCTR2022-000161-40-ATMedical University of Vienna, Division of Endocrinology50
Recruiting
Unknown
Metabolomic Profiling and Cardiovascular Outcomes in Patients with Cirrhotic Cardiomyopathy Undergoing Liver TransplantationCirrhosisCirrhotic cardiomyopathyLiver transplantationOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonCardiovascular - Other cardiovascular diseasesACTRN12624001166561Dr Madeleine Gill150